The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
phenyl 5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[1,2-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-ylcarbamate ID: ALA4760391
PubChem CID: 72549795
Max Phase: Preclinical
Molecular Formula: C29H31F3N8O5S
Molecular Weight: 660.68
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(NC(=O)Oc5ccccc5)cc4C(F)(F)F)nn3c2)CC1
Standard InChI: InChI=1S/C29H31F3N8O5S/c1-46(42,43)39-9-7-37(8-10-39)18-20-15-24-27(38-11-13-44-14-12-38)35-26(36-40(24)19-20)22-17-33-25(16-23(22)29(30,31)32)34-28(41)45-21-5-3-2-4-6-21/h2-6,15-17,19H,7-14,18H2,1H3,(H,33,34,41)
Standard InChI Key: SKQAETTVBZVFCK-UHFFFAOYSA-N
Molfile:
RDKit 2D
46 51 0 0 0 0 0 0 0 0999 V2000
32.7750 -10.1050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5899 -10.1033 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.1804 -9.3961 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.2319 -13.3372 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.5232 -12.9284 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5201 -13.7456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6607 -11.3251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3660 -10.9206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3660 -10.1035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6607 -9.6907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9554 -10.9206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9555 -10.0989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1740 -9.8449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6909 -10.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1739 -11.1745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6598 -8.8702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3765 -8.4612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3776 -7.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6684 -7.2309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9564 -7.6407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9536 -8.4639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0713 -11.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0688 -12.1475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7750 -12.5570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4843 -12.1494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4829 -11.3280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7760 -10.9222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1903 -12.5614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8737 -10.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4651 -11.2174 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6465 -11.2172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2380 -11.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6431 -12.6310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4613 -12.6330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8743 -11.9248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6378 -14.0464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0667 -9.6973 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.8999 -12.1560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6057 -12.5679 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.9037 -11.3389 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.3153 -12.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0175 -12.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7266 -12.1706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7308 -11.3526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0200 -10.9409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3138 -11.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 0
5 4 2 0
4 6 2 0
12 10 1 0
11 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
10 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
8 22 1 0
25 28 1 0
14 29 1 0
29 30 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
33 4 1 0
4 36 1 0
27 1 1 0
1 37 1 0
28 38 1 0
38 39 1 0
38 40 2 0
39 41 1 0
41 42 2 0
42 43 1 0
43 44 2 0
44 45 1 0
45 46 2 0
46 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 660.68Molecular Weight (Monoisotopic): 660.2090AlogP: 3.33#Rotatable Bonds: 7Polar Surface Area: 134.50Molecular Species: NEUTRALHBA: 11HBD: 1#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.67CX Basic pKa: 5.59CX LogP: 4.38CX LogD: 4.37Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.31Np Likeness Score: -1.75
References 1. Xiang HY,Wang X,Chen YH,Zhang X,Tan C,Wang Y,Su Y,Gao ZW,Chen XY,Xiong B,Gao ZB,Chen Y,Ding J,Meng LH,Yang CH. (2021) Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumors., 209 [PMID:33109399 ] [10.1016/j.ejmech.2020.112913 ]